Clinical Trial Update: Effects of Nitric Oxide for Inhalation in Myocardial Infarction Size [Phase 2]

View source ↗

Summary

Phase 2 study evaluating inhaled nitric oxide to reduce myocardial infarction size in patients with acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Nitric oxide inhalation (nitric oxide)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Acute Myocardial Infarction | Phase 2 | Status: COMPLETED